(BUSINESS WIRE)--Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the company will highlight its pipeline of DNA vaccines and electroporation delivery technology in a presentation and discuss vaccine product development in panel discussions at the Phacilitate Vaccine Forum Washington 2011, being held January 24-26 at the Grand Hyatt Washington in Washington, D.C.
